Format
Items per page

Send to:

Choose Destination

Links from PubMed

Items: 18

1.

Acute myeloid leukemia

CEBPA- associated familial acute myeloid leukemia (AML) is defined as AML in which a heterozygous germlineCEBPApathogenic variant is present in a family in which multiple individuals have AML. In contrast, sporadicCEBPA-associated AML is defined as AML in which aCEBPApathogenic variant(s) is identified in leukemic cells but not in the non-leukemic cells. Too few individuals withCEBPA-associated familial AML have been reported to be certain about the natural history of the disease. In the majority of individuals, the age of onset of familial AML appears to be earlier than sporadic AML; disease onset has been reported in persons as young as age 1.8 years and older than age 45 years. The prognosis ofCEBPA-associated familial AML appears to be favorable compared with sporadicCEBPA-associated AML. Individuals withCEBPA-associated familial AML who have been cured of their initial disease may be at greater risk of developing additional independent leukemic episodes in addition to the risk of relapse due to preexisting clones. [from GeneReviews]

MedGen UID:
9730
Concept ID:
C0023467
Neoplastic Process
2.

Leukemia

MedGen UID:
9725
Concept ID:
C0023418
Neoplastic Process
3.

Transplantation

MedGen UID:
881115
Concept ID:
CN236682
Disease or Syndrome
4.

Acute myeloid leukemia

MedGen UID:
505691
Concept ID:
CN004254
Finding
5.

Myeloid leukemia

MedGen UID:
7320
Concept ID:
C0023470
Neoplastic Process
6.

Worse

In an declined condition. [from NCI]

MedGen UID:
264163
Concept ID:
C1457868
Finding
7.

Remission phase

An abatement in intensity or degree (as in the manifestations of a disease). [from NCI]

MedGen UID:
154255
Concept ID:
C0544452
Finding
8.

In full remission

The disappearance of all signs of cancer in response to treatment. [from NCI]

MedGen UID:
146208
Concept ID:
C0677874
Finding
9.

Adopted

Having been legally made a member of a family. [from NCI]

MedGen UID:
98081
Concept ID:
C0425382
Finding
10.

Acute

Sudden appearance of disease manifestations over a short period of time. [from HPO]

MedGen UID:
61381
Concept ID:
C0205178
Temporal Concept
11.

Central

Applies to an abnormality that is located close to the median plane or midline of the body or of the referenced structure. [from HPO]

MedGen UID:
59958
Concept ID:
C0205099
Spatial Concept
12.

Acute myeloid leukemia with maturation

MedGen UID:
361829
Concept ID:
C1879321
Neoplastic Process
13.

Neoplasms by Histologic Type

A collective term for the various histological types of NEOPLASMS. It is more likely to be used by searchers than by indexers and catalogers. [from MeSH]

MedGen UID:
10295
Concept ID:
C0027652
Neoplastic Process
14.

Chronic Monocytic Leukemia

MedGen UID:
9729
Concept ID:
C0023466
Neoplastic Process
15.

Acute Myeloid Leukemia with FLT3/ITD Mutation

Acute myeloid leukemia characterized by the presence of a FLT3-internal tandem duplication (ITD) mutation. Patients with this mutation usually present with more aggressive disease and have higher rates of relapse after remission. [from NCI]

MedGen UID:
927531
Concept ID:
C4289999
Neoplastic Process
16.

Early Relapse of Acute Myeloid Leukemia

Clinical and/or laboratory evidence of reemergence of acute myeloid leukemia less than 12 months from diagnosis. [from NCI]

MedGen UID:
886107
Concept ID:
C4053782
Finding
17.

Patient in early remission

MedGen UID:
736764
Concept ID:
C1562799
Finding
18.

Presenting part not seen

MedGen UID:
650717
Concept ID:
C0566833
Finding
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center